Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Genetic Restoration of Heme Oxygenase-1 Expression Protects from Type 1 Diabetes in NOD Mice.

Pogu J, Tzima S, Kollias G, Anegon I, Blancou P, Simon T.

Int J Mol Sci. 2019 Apr 3;20(7). pii: E1676. doi: 10.3390/ijms20071676.

2.

Apical splenic nerve electrical stimulation discloses an anti-inflammatory pathway relying on adrenergic and nicotinic receptors in myeloid cells.

Guyot M, Simon T, Panzolini C, Ceppo F, Daoudlarian D, Murris E, Macia E, Abélanet S, Sridhar A, Vervoordeldonk MJ, Glaichenhaus N, Blancou P.

Brain Behav Immun. 2019 Mar 15. pii: S0889-1591(18)31246-7. doi: 10.1016/j.bbi.2019.03.015. [Epub ahead of print]

3.

The OncoAge Consortium: Linking Aging and Oncology from Bench to Bedside and Back Again.

Hofman P, Ayache N, Barbry P, Barlaud M, Bel A, Blancou P, Checler F, Chevillard S, Cristofari G, Demory M, Esnault V, Falandry C, Gilson E, Guérin O, Glaichenhaus N, Guigay J, Ilié M, Mari B, Marquette CH, Paquis-Flucklinger V, Prate F, Saintigny P, Seitz-Polsky B, Skhiri T, Van Obberghen-Schilling E, Van Obberghen E, Yvan-Charvet L.

Cancers (Basel). 2019 Feb 21;11(2). pii: E250. doi: 10.3390/cancers11020250.

4.

Loss of intestinal sympathetic innervation elicits an innate immune driven colitis.

Willemze RA, Welting O, van Hamersveld P, Verseijden C, Nijhuis LE, Hilbers FW, Meijer SL, Heesters BA, Folgering JHA, Darwinkel H, Blancou P, Vervoordeldonk MJ, Seppen J, Heinsbroek SEM, de Jonge WJ.

Mol Med. 2019 Jan 7;25(1):1. doi: 10.1186/s10020-018-0068-8.

5.

Inhibition of effector antigen-specific T cells by intradermal administration of heme oxygenase-1 inducers.

Simon T, Pogu J, Rémy S, Brau F, Pogu S, Maquigneau M, Fonteneau JF, Poirier N, Vanhove B, Blancho G, Piaggio E, Anegon I, Blancou P.

J Autoimmun. 2017 Jul;81:44-55. doi: 10.1016/j.jaut.2017.03.005. Epub 2017 Mar 23.

PMID:
28342735
6.

Epithelial stem cells as mucosal antigen-delivering cells: A novel AIDS vaccine approach.

White R, Chenciner N, Bonello G, Salas M, Blancou P, Gauduin MC.

Vaccine. 2015 Nov 27;33(48):6914-21. doi: 10.1016/j.vaccine.2013.09.006. Epub 2013 Nov 25.

7.

Carbon monoxide decreases endosome-lysosome fusion and inhibits soluble antigen presentation by dendritic cells to T cells.

Tardif V, Riquelme SA, Remy S, Carreño LJ, Cortés CM, Simon T, Hill M, Louvet C, Riedel CA, Blancou P, Bach JM, Chauveau C, Bueno SM, Anegon I, Kalergis AM.

Eur J Immunol. 2013 Nov;43(11):2832-44. doi: 10.1002/eji.201343600. Epub 2013 Aug 21.

8.

β2-Adrenoreceptor agonist inhibits antigen cross-presentation by dendritic cells.

Hervé J, Dubreil L, Tardif V, Terme M, Pogu S, Anegon I, Rozec B, Gauthier C, Bach JM, Blancou P.

J Immunol. 2013 Apr 1;190(7):3163-71. doi: 10.4049/jimmunol.1201391. Epub 2013 Feb 18.

9.

Carbon monoxide-treated dendritic cells decrease β1-integrin induction on CD8⁺ T cells and protect from type 1 diabetes.

Simon T, Pogu S, Tardif V, Rigaud K, Rémy S, Piaggio E, Bach JM, Anegon I, Blancou P.

Eur J Immunol. 2013 Jan;43(1):209-18. doi: 10.1002/eji.201242684. Epub 2012 Dec 11.

10.

Penicillin binding proteins as danger signals: meningococcal penicillin binding protein 2 activates dendritic cells through Toll-like receptor 4.

Hill M, Deghmane AE, Segovia M, Zarantonelli ML, Tilly G, Blancou P, Bériou G, Josien R, Anegon I, Hong E, Ruckly C, Antignac A, El Ghachi M, Boneca IG, Taha MK, Cuturi MC.

PLoS One. 2011;6(10):e23995. doi: 10.1371/journal.pone.0023995. Epub 2011 Oct 27.

11.

Heme oxygenase and carbon monoxide as an immunotherapeutic approach in transplantation and cancer.

Simon T, Anegon I, Blancou P.

Immunotherapy. 2011 Apr;3(4 Suppl):15-8. doi: 10.2217/imt.11.43. Review.

PMID:
21524161
12.

Immunoregulatory properties of heme oxygenase-1.

Blancou P, Tardif V, Simon T, Rémy S, Carreño L, Kalergis A, Anegon I.

Methods Mol Biol. 2011;677:247-68. doi: 10.1007/978-1-60761-869-0_18.

PMID:
20941616
13.

Editorial: Heme oxygenase-1 and dendritic cells: what else?

Blancou P, Anegon I.

J Leukoc Biol. 2010 Feb;87(2):185-7. doi: 10.1189/jlb.0909636. No abstract available.

PMID:
20123679
14.

Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity.

Rémy S, Blancou P, Tesson L, Tardif V, Brion R, Royer PJ, Motterlini R, Foresti R, Painchaut M, Pogu S, Gregoire M, Bach JM, Anegon I, Chauveau C.

J Immunol. 2009 Feb 15;182(4):1877-84. doi: 10.4049/jimmunol.0802436.

15.

Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice.

Enée E, Martinuzzi E, Blancou P, Bach JM, Mallone R, van Endert P.

J Immunol. 2008 Apr 15;180(8):5430-8.

16.

The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.

Martinuzzi E, Novelli G, Scotto M, Blancou P, Bach JM, Chaillous L, Bruno G, Chatenoud L, van Endert P, Mallone R.

Diabetes. 2008 May;57(5):1312-20. doi: 10.2337/db07-1594. Epub 2008 Feb 27.

17.

Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients.

Blancou P, Mallone R, Martinuzzi E, Sévère S, Pogu S, Novelli G, Bruno G, Charbonnel B, Dolz M, Chaillous L, van Endert P, Bach JM.

J Immunol. 2007 Jun 1;178(11):7458-66.

18.

CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes.

Mallone R, Martinuzzi E, Blancou P, Novelli G, Afonso G, Dolz M, Bruno G, Chaillous L, Chatenoud L, Bach JM, van Endert P.

Diabetes. 2007 Mar;56(3):613-21.

19.

HLA class I epitope discovery in type 1 diabetes.

van Endert P, Hassainya Y, Lindo V, Bach JM, Blancou P, Lemonnier F, Mallone R.

Ann N Y Acad Sci. 2006 Oct;1079:190-7.

PMID:
17130554
20.

Supplemental Content

Loading ...
Support Center